DrugPatentWatch Database Preview
Pharmalucence Company Profile
What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?
PHARMALUCENCE has fourteen approved drugs.
Summary for Pharmalucence
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 13 |
| NDAs: | 14 |
Drugs and US Patents for Pharmalucence
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmalucence | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmalucence | OSTEOLITE | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 017972-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmalucence | CIS-PYRO | technetium tc-99m pyrophosphate kit | INJECTABLE;INJECTION | 019039-001 | Jun 30, 1987 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Pharmalucence
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | 4,584,187 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
